Repression of arterial genes in hemogenic endothelium is sufficient for haematopoietic fate acquisition

Autor: Zovein, Ann, Lizama, CO, Hawkins, JS, Schmitt, CE, Bos, FL, Zape, JP, Cautivo, KM, Borges, H, Rhyner, AM, Yu, H, Donohoe, ME

Publikováno v: Zovein, Ann; Lizama, CO; Hawkins, JS; Schmitt, CE; Bos, FL; Zape, JP; et al.(2015). Repression of arterial genes in hemogenic endothelium is sufficient for haematopoietic fate acquisition. UC San Francisco: Retrieved from: http://www.escholarship.org/uc/item/0k34d940

© 2015 Macmillan Publishers Limited.Changes in cell fate and identity are essential for endothelial-to-haematopoietic transition (EHT), an embryonic process that generates the first adult populations of haematopoietic stem cells (HSCs) from hemogeni

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od_______325::9c2ca8b927e9ae0ae1e34b20c3e1908b
http://www.escholarship.org/uc/item/0k34d940

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Identification of HTRA4 as a Transcriptional Target of p63 in Trophoblast.

Autor: Donohoe ME; Department of Pathology, University of California San Diego, La Jolla, California; Sanford Consortium for Regenerative Medicine, University of California San Diego, La Jolla, California., Morey R; Department of Pathology, University of California San Diego, La Jolla, California; Sanford Consortium for Regenerative Medicine, University of California San Diego, La Jolla, California., Li Y; Center for Genes, Environment, and Health, National Jewish Health, Denver, Colorado., Pizzo D; Department of Pathology, University of California San Diego, La Jolla, California., Kallol S; Department of Pathology, University of California San Diego, La Jolla, California; Sanford Consortium for Regenerative Medicine, University of California San Diego, La Jolla, California., Cho HY; Department of Obstetrics and Gynecology, Seoul National University College of Medicine, Seoul, Republic of Korea., Soncin F; Department of Pathology, University of California San Diego, La Jolla, California; Sanford Consortium for Regenerative Medicine, University of California San Diego, La Jolla, California., Parast MM; Department of Pathology, University of California San Diego, La Jolla, California; Sanford Consortium for Regenerative Medicine, University of California San Diego, La Jolla, California. Electronic address: mparast@health.ucsd.edu.

Publikováno v: The American journal of pathology [Am J Pathol] 2024 Jul; Vol. 194 (7), pp. 1162-1170.

Inflammation-driven deaminase deregulation fuels human pre-leukemia stem cell evolution.

Autor: Jiang Q; Division of Regenerative Medicine, Department of Medicine, Moores Cancer Center, University of California, San Diego, La Jolla, CA 92093-0820, USA., Isquith J; Division of Regenerative Medicine, Department of Medicine, Moores Cancer Center, University of California, San Diego, La Jolla, CA 92093-0820, USA., Ladel L; Division of Regenerative Medicine, Department of Medicine, Moores Cancer Center, University of California, San Diego, La Jolla, CA 92093-0820, USA., Mark A; Center for Computational Biology & Bioinformatics (CCBB), Department of Medicine, University of California, San Diego, La Jolla, CA 92093-0681, USA., Holm F; Karolinska Institutet, Stockholm, Sweden., Mason C; Division of Regenerative Medicine, Department of Medicine, Moores Cancer Center, University of California, San Diego, La Jolla, CA 92093-0820, USA., He Y; Department of Cellular and Molecular Medicine and Department of Bioengineering and Moores Cancer Center, University of California, San Diego, La Jolla, CA 92093, USA., Mondala P; Division of Regenerative Medicine, Department of Medicine, Moores Cancer Center, University of California, San Diego, La Jolla, CA 92093-0820, USA., Oliver I; Division of Regenerative Medicine, Department of Medicine, Moores Cancer Center, University of California, San Diego, La Jolla, CA 92093-0820, USA., Pham J; Division of Regenerative Medicine, Department of Medicine, Moores Cancer Center, University of California, San Diego, La Jolla, CA 92093-0820, USA., Ma W; Division of Regenerative Medicine, Department of Medicine, Moores Cancer Center, University of California, San Diego, La Jolla, CA 92093-0820, USA., Reynoso E; Division of Regenerative Medicine, Department of Medicine, Moores Cancer Center, University of California, San Diego, La Jolla, CA 92093-0820, USA., Ali S; Division of Regenerative Medicine, Department of Medicine, Moores Cancer Center, University of California, San Diego, La Jolla, CA 92093-0820, USA., Morris IJ; Division of Regenerative Medicine, Department of Medicine, Moores Cancer Center, University of California, San Diego, La Jolla, CA 92093-0820, USA., Diep R; Division of Regenerative Medicine, Department of Medicine, Moores Cancer Center, University of California, San Diego, La Jolla, CA 92093-0820, USA., Nasamran C; Center for Computational Biology & Bioinformatics (CCBB), Department of Medicine, University of California, San Diego, La Jolla, CA 92093-0681, USA., Xu G; Center for Computational Biology & Bioinformatics (CCBB), Department of Medicine, University of California, San Diego, La Jolla, CA 92093-0681, USA., Sasik R; Center for Computational Biology & Bioinformatics (CCBB), Department of Medicine, University of California, San Diego, La Jolla, CA 92093-0681, USA., Rosenthal SB; Center for Computational Biology & Bioinformatics (CCBB), Department of Medicine, University of California, San Diego, La Jolla, CA 92093-0681, USA., Birmingham A; Center for Computational Biology & Bioinformatics (CCBB), Department of Medicine, University of California, San Diego, La Jolla, CA 92093-0681, USA., Coso S; Division of Regenerative Medicine, Department of Medicine, Moores Cancer Center, University of California, San Diego, La Jolla, CA 92093-0820, USA., Pineda G; Division of Regenerative Medicine, Department of Medicine, Moores Cancer Center, University of California, San Diego, La Jolla, CA 92093-0820, USA., Crews L; Division of Regenerative Medicine, Department of Medicine, Moores Cancer Center, University of California, San Diego, La Jolla, CA 92093-0820, USA., Donohoe ME; Division of Regenerative Medicine, Department of Medicine, Moores Cancer Center, University of California, San Diego, La Jolla, CA 92093-0820, USA., Venter JC; J. Craig Venter Institute, La Jolla, CA 92037, USA., Whisenant T; Center for Computational Biology & Bioinformatics (CCBB), Department of Medicine, University of California, San Diego, La Jolla, CA 92093-0681, USA., Mesa RA; Mays Cancer Center at UT Health San Antonio MD Anderson, UT Health San Antonio, San Antonio, TX 78229, USA., Alexandrov LB; Department of Cellular and Molecular Medicine and Department of Bioengineering and Moores Cancer Center, University of California, San Diego, La Jolla, CA 92093, USA. Electronic address: l2alexandrov@health.ucsd.edu., Fisch KM; Center for Computational Biology & Bioinformatics (CCBB), Department of Medicine, University of California, San Diego, La Jolla, CA 92093-0681, USA. Electronic address: kfisch@health.ucsd.edu., Jamieson C; Division of Regenerative Medicine, Department of Medicine, Moores Cancer Center, University of California, San Diego, La Jolla, CA 92093-0820, USA. Electronic address: cjamieson@health.ucsd.edu.

Publikováno v: Cell reports [Cell Rep] 2021 Jan 26; Vol. 34 (4), pp. 108670.